A novel modulation of structural and functional changes of mouse bone marrow derived dendritic cells (BMDCs) by interleukin-2(IL-2)

References

• Smith KA, Lachman LB, Oppenheim JJ, Favata MF. The functional relationship of the interleukins. J Exp Med 1980June,151(6):1551-6; http://dx.doi.org/10.1084/jem.151.6.1551.
   PubMed Web of Science ®Google Scholar
• Smith KA, Gilbride KJ, Favata MF. Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. Nature 1980 October, 287 (5785):853-5.
   PubMed Web of Science ®Google Scholar
• Robb RJ, Smith KA. Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. Mol Immunol 1981December 18 (12): 1087-94; http://dx.doi.org/10.1016/0161-5890(81)90024-9.
   PubMed Web of Science ®Google Scholar
• Abraham S, Pahwa R, Ye C, Choi JG, Pahwa S, Jaggaiahgari S, et al. Long-Term Engraftment of Human Natural T Regulatory Cells in NOD/SCID IL2rγc(null) Mice by Expression of Human IL-2. PLoS One 2012;7(12):e51832; PMID:23272176; http://dx.doi.org/10.1371/journal.pone.0051832.
   PubMedGoogle Scholar
• Smith KA, Favata MF, Oroszlan S . Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol 1983 October 131 (4): 1808-15.
   PubMed Web of Science ®Google Scholar
• Ahn YO, Lee JC, Sung MW, Heo DS. Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines. J Immunol 2009 May 15; 182(10):6114-20; http://dx.doi.org/10.4049/jimmunol.0803725.
   PubMed Web of Science ®Google Scholar
• Wojas-Turek J, Pajtasz-Piasecka E, Rossowska J, Piasecki E, Duś D. Antitumor effect of murine dendritic and tumor cells transduced with IL-2 gene. Folia Histochem Cytobiol. 2012 Oct 8;50(3): 414-9; http://dx.doi.org/10.5603/FHC.2012.0056.
   PubMed Web of Science ®Google Scholar
• Lissoni P, Brivio F, Fumagalli L, Messina G, Vigoré L, Parolini D, et al. Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors. Anticancer Res. 2008 Mar-Apr; 28(2B):1377-81.
   PubMed Web of Science ®Google Scholar
• Liu J, Chen W, Meng J, Lu C, Wang E, Shan F. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK). Cancer Immunol Immunother 2012 Oct; 61(10):1699-711; http://dx.doi.org/10.1007/s00262-012-1221-9.
   PubMed Web of Science ®Google Scholar
• Xue M, Zhu L, Meng Y, Wang L, Sun H, Wang F, et al. Detailed modulation of phenotypes and functions of bone marrow dendritic cells (BMDCs) by interferon-gamma (IFN-γ). Int Immunopharmacol 2013 Jul 16;17(2):366-372; http://dx.doi.org/10.1016/j.intimp.2013.07.002.
   PubMed Web of Science ®Google Scholar
• Meng Y, Wang Q, Zhang Z, Wang E, Plotnikoff NP, Shan F. Synergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs). Hum Vaccin Immunother 2013 Mar 7;9(4).
   Web of Science ®Google Scholar
• Steinman, R and Cohn Z. Identification of a novel cell type in peripheral lymphoid organs of mice. J Exp Med 1973; 137: 1142-62; PMID:4573839; http://dx.doi.org/10.1084/jem.137.5.1142.
   PubMed Web of Science ®Google Scholar
• Mnasria K, Lagaraine C, Manaa J, Lebranchu Y, Oueslati R. IL-2/IL-2R pathway in dendritic cell modulates both their cytokine synthesis profiles and their capacity to activate allogeneic CD4+ T lymphocytes. Pathol Biol 2011;59(3): 29-35; PMID:21277703; http://dx.doi.org/10.1016/j.patbio.2009.03.002.
   PubMedGoogle Scholar
• Kradin RL, Xia W, Pike M, Byers HR, Pinto C. Interleukin-2 promotes the motility of dendritic cells and their accumulation in lung and skin. Pathobiology 1996;64(4):180-6; PMID:9031326; http://dx.doi.org/10.1159/000164033.
   PubMedGoogle Scholar
• Zelante T, Fric J, Wong AY, Ricciardi-Castagnoli P. Interleukin-2 production by dendritic cells and its immune-regulatory functions. Front Immunol 2012;3:161; PMID:22719740; http://dx.doi.org/10.3389/fimmu.2012.00161.
   PubMedGoogle Scholar
• Naranjo-Gómez M, Oliva H, Climent N, Ferna´ndez MA, Ruiz-Riol M, Bofill M, et al. Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells. Eur J Immunol 2007;37:1764-1772; http://dx.doi.org/10.1002/eji.200636980.
   PubMed Web of Science ®Google Scholar
• Bykovskaja SN, Buffo MJ, Bunker M, Zhang H, Majors A, Herbert M, et al. Interleukin-2-induces development of denditric cells from cord blood CD34+ cells. J Leukoc Biol 1998;63(5):620-30; PMID:9581807.
   PubMed Web of Science ®Google Scholar
• Cândido EB, Silva LM, Carvalho AT, Lamaita RM, Filho RM, Cota BD, et al. Immune Response Evaluation Through Determination of Type 1, Type 2, and Type 17 Patterns in Patients With Epithelial Ovarian Cancer. Reprod Sci 2012 Dec 13.
   Web of Science ®Google Scholar
• Kim D, Suh Y, Lee H, Lee Y. Immune activation and antitumor response of ar-turmerone on P388D1 lymphoblast cell implanted tumors. Int J Mol Med 2012 Nov 29.
   Web of Science ®Google Scholar
• Gerber SA, Sorensen EW, Sedlacek AL, Lim JY, Skrombolas D, Frelinger JG, et al. Local expression of IL-2 by B16 melanoma cells results in decreased tumor growth and long-term tumor dormancy. Immunology 2012 Nov 30.
   Google Scholar
• Inaba H, Geiger TL. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes. Int Immunol 2006 Jul;18(7):1043-54; http://dx.doi.org/10.1093/intimm/dxl038.
   PubMed Web of Science ®Google Scholar
• Farrer DG, Hueber S, Laiosa MD, Eckles KG, McCabe MJ Jr. Reduction of myeloid suppressor cell derived nitric oxide provides a mechanistic basis of lead enhancement of alloreactive CD4(+) T cell proliferation. Toxicol Appl Pharmacol 2008 Jun 1;229(2):135-45; http://dx.doi.org/10.1016/j.taap.2007.12.011.
   PubMed Web of Science ®Google Scholar
• Chu MB, Fesler MJ, Armbrecht ES, Fosko SW, Hsueh E, Richart JM. High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain Metastases. Chemother Res Pract 2013:726925; http://dx.doi.org/10.1155/2013/726925.
   Google Scholar
• Stark R, Hartung A, Zehn D, Frentsch M, Thiel A. IL-12-mediated STAT4 signaling and TCR signal strength cooperate in the induction of CD40L in human and mouse CD8+ T cells. Eur J Immunol 2013 Apr 4;43(6):1511-1517; http://dx.doi.org/10.1002/eji.201243218.
   PubMed Web of Science ®Google Scholar
• Feng X, Feng G, Xing J, Shen B, Li L, Tan W, Xu Y, et al.TNF-α triggers osteogenic differentiation of human dental pulp stem cells via the NF-κB signaling pathway. Cell Biol Int 2013 Jun 13; http://dx.doi.org/10.1002/cbin.10141.
   Web of Science ®Google Scholar
• Jiang CY, Wang W, Tang JX, Yuan ZR. The adipocytokine resistin stimulates production of proinflammatory cytokines TNF-α and IL-6 in pancreatic acinar cells via NF-κB activation. J Endocrinol Invest 2013 Jun 10.
   Web of Science ®Google Scholar
• Philips G, Atkins MB. Is interleukin 2 the best initial therapy for many patients with metastatic renal cell carcinoma? Cancer J 2013 May-Jun;19(3):197-8; http://dx.doi.org/10.1097/PPO.0b013e318292e6a2.
   PubMed Web of Science ®Google Scholar
• Subramani B, Ratnavelu K, Pullai CR, Krishnan K, Sugadan SD, Deng X, et al. Autologous immune enhancement therapy: A case report of a stage IV colonic cancer. . Oncol Lett 2013 May;5(5):1611-1614.
   PubMed Web of Science ®Google Scholar
• Chiarion-Sileni V, Guida M, Romanini A, Bernengo MG, Ascierto P, Queirolo P, et al. Diagnostic and therapeutic approaches in italian hospitals: adjuvant and metastatic therapy in melanoma. Dermatology 2013;226 Suppl 1:22-7; PMID:23736267; http://dx.doi.org/10.1159/000348870.
   PubMedGoogle Scholar
• Yoshizato T, Nannya Y, Imai Y, Ichikawa M, Kurokawa M. Clinical Significance of Serum-Soluble Interleukin-2 Receptor in Patients With Follicular Lymphoma. Clin Lymphoma Myeloma Leuk 2013 Jun 5. pii: S2152-2650(13)00114-6.
   Google Scholar
• Morris D, Gonzalez B, Khurasany M, Kassissa C, Luong J, Kasko S, Pandya S, et al. Characterization of Dendritic Cell and Regulatory T Cell Functions against Mycobacterium tuberculosis Infection. Biomed Res Int 2013;2013:402827; PMID:23762843; http://dx.doi.org/10.1155/2013/402827.
   PubMedGoogle Scholar
• Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Uchiyama K, et al. Fusions between dendritic cells and whole tumor cells as anticancer vaccines. Oncoimmunology 2013 May 1;2(5):e24437; http://dx.doi.org/10.4161/onci.24437.
   PubMed Web of Science ®Google Scholar
• Segura E, Amigorena S. Identification of human inflammatory dendritic cells. Oncoimmunology 2013 May 1;2(5):e23851; http://dx.doi.org/10.4161/onci.23851.
   PubMed Web of Science ®Google Scholar
• Chung CY, Ysebaert D, Berneman ZN, Cools N. Dendritic cells: cellular mediators for immunological tolerance. Clin Dev Immunol 2013;2013:972865.; PMID:23762100; http://dx.doi.org/10.1155/2013/972865.
   PubMedGoogle Scholar
• Segovia M, Cuturi MC, Hill M. Preparation of mouse bone marrow-derived dendritic cells with immunoregulatory properties. Methods Mol Biol 2011;677:161-8; PMID:20941609; http://dx.doi.org/10.1007/978-1-60761-869-0_11.
   PubMedGoogle Scholar
• Abbasi H1, Tahmoorespur M, Hosseini SM, Nasiri Z, Bahadorani M, Hajian M, et al. THY1 as a reliable marker for enrichment of undifferentiated spermatogonia in the goat. Theriogenology 2013; 80:923-932; http://dx.doi.org/10.1016/j.theriogenology.2013.07.020.
   PubMed Web of Science ®Google Scholar
• Wu J1, Song W, Zhu H, Niu Z, Mu H, Lei A, et al. Enrichment and characterization of Thy1-positive male germline stem cells (mGSCs) from dairy goat (Capra hircus) testis using magnetic microbeads. Theriogenology 2013; 80:1052-1060; http://dx.doi.org/10.1016/j.theriogenology.2013.08.003.
   PubMed Web of Science ®Google Scholar
• Fukao T, Koyasu S. Expression of functional IL-2 receptors on mature splenic dendritic cells.Eur J Immunol 2000;30(5):1453-7; PMID:10820393; http://dx.doi.org/10.1002/(SICI)1521-4141(200005)30:5%3c1453::AID-IMMU1453%3e3.0.CO;2-W.
   PubMedGoogle Scholar